GeneDx Holdings Corp. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GeneDx Holdings Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • GeneDx Holdings Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.78M, a 81.9% increase year-over-year.
  • GeneDx Holdings Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$57.7M, a 88% increase year-over-year.
  • GeneDx Holdings Corp. annual Operating Income (Loss) for 2023 was -$181M, a 73% increase from 2022.
  • GeneDx Holdings Corp. annual Operating Income (Loss) for 2022 was -$668M, a 49.6% decline from 2021.
  • GeneDx Holdings Corp. annual Operating Income (Loss) for 2021 was -$446M, a 84.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$181M +$487M +73% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 -$668M -$222M -49.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 -$446M -$204M -84.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$242M -$212M -696% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$30.4M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.